HYDROMORPHONE HYDROCHLORIDE

HYDROMORPHONE HYDROCHLORIDE was reported 91828 times

HYDROMORPHONE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 225 0.7426
1 ANTACID THERAPY 76 0.5846
2 SLEEP DISORDER THERAPY 109 0.5505
3 APPENDICOLITH 175 0.4522
4 INSPIRATORY CAPACITY DECREASED 99 0.3574
5 ANALGESIC THERAPY 114 0.3551
6 DRUG THERAPY 114 0.3363
7 LEARNING DISABILITY 1553 0.2914
8 NEONATAL HYPOACUSIS 63 0.2636
9 CONGENITAL HIATUS HERNIA 60 0.2632
10 VISION ABNORMAL NEONATAL 109 0.2608
11 ANTICOAGULANT THERAPY 74 0.2606
12 MALIGNANT MELANOMA STAGE 0 49 0.2344
13 DRUG DEPENDENCE 35119 0.2182
14 DRUG WITHDRAWAL SYNDROME NEONATAL 2771 0.1870
15 DRUG WITHDRAWAL SYNDROME 14329 0.1631
16 TEMPERATURE REGULATION DISORDER 352 0.1578
17 DEVELOPMENTAL DELAY 1388 0.1537
18 SUBSTANCE DEPENDENCE 103 0.1530
19 EMOTIONAL DISTRESS 17705 0.1461
20 FEMALE GENITAL TRACT FISTULA 243 0.1422
21 AMAUROSIS FUGAX 145 0.1346
22 SELF ESTEEM DECREASED 309 0.1275
23 RETINITIS 217 0.1255
24 SOFT TISSUE DISORDER 125 0.1127
25 OVERDOSE 23079 0.1069
26 RADICULOPATHY 266 0.1008
27 DRUG TOLERANCE INCREASED 76 0.0973
28 NASAL OEDEMA 170 0.0940
29 LUPUS VULGARIS 118 0.0937
30 PROCTITIS 236 0.0842
31 HYPERMOBILITY SYNDROME 41 0.0823
32 IMPRISONMENT 140 0.0791
33 MEDICAL DEVICE SITE PAIN 44 0.0782
34 IMPLANT SITE EXTRAVASATION 61 0.0776
35 SUBSTANCE USE DISORDER 247 0.0775
36 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 50 0.0749
37 BONE EROSION 255 0.0720
38 CHRONIC SINUSITIS 267 0.0711
39 SPINA BIFIDA 141 0.0676
40 DRUG TOLERANCE 340 0.0671
41 HYPERPHOSPHATAEMIA 141 0.0655
42 DRUG DIVERSION 388 0.0628
43 SUBSTANCE ABUSE 507 0.0622
44 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 56 0.0604
45 FOOD ALLERGY 464 0.0601
46 TOXICITY TO VARIOUS AGENTS 10084 0.0597
47 POST-TRAUMATIC STRESS DISORDER 387 0.0577
48 BLOOD PHOSPHORUS INCREASED 152 0.0556
49 MULTIPLE CONGENITAL ABNORMALITIES 80 0.0556
50 FACET JOINT SYNDROME 177 0.0543
51 MACULAR DEGENERATION 634 0.0530
52 FOETAL DEATH 274 0.0528
53 PNEUMONIA VIRAL 168 0.0526
54 DISABILITY 897 0.0453
55 STREPTOCOCCAL SEPSIS 53 0.0447
56 BURSITIS 541 0.0445
57 JUDGEMENT IMPAIRED 60 0.0413
58 EXPOSURE VIA FATHER 53 0.0406
59 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 290 0.0404
60 TOTAL LUNG CAPACITY DECREASED 64 0.0401
61 EXOSTOSIS 365 0.0399
62 SYNOVITIS 700 0.0388
63 PERIPHERAL VENOUS DISEASE 158 0.0386
64 RHEUMATOID FACTOR POSITIVE 223 0.0386
65 DRUG ABUSE 3128 0.0375
66 CONGENITAL ANOMALY 285 0.0368
67 PAIN 22354 0.0364
68 IMMUNODEFICIENCY 518 0.0347
69 COMPLEX REGIONAL PAIN SYNDROME 51 0.0345
70 RESPIRATORY RATE DECREASED 107 0.0340
71 SWOLLEN JOINT COUNT INCREASED 107 0.0335
72 INFUSION SITE REACTION 100 0.0334
73 URINARY TRACT DISORDER 150 0.0333
74 HEPATITIS C 393 0.0325
75 COELIAC DISEASE 318 0.0324
76 RHEUMATIC FEVER 142 0.0318
77 BLEPHAROSPASM 200 0.0317
78 MENTAL DISORDER 1338 0.0307
79 GENERAL PHYSICAL CONDITION ABNORMAL 206 0.0303
80 RED BLOOD CELL SEDIMENTATION RATE INCREASED 330 0.0298
81 PSEUDOMONAL SEPSIS 52 0.0297
82 HYPERCHOLESTEROLAEMIA 278 0.0288
83 JOINT DISLOCATION 296 0.0280
84 IRON DEFICIENCY 124 0.0275
85 DUODENAL ULCER PERFORATION 201 0.0270
86 PLEURITIC PAIN 74 0.0268
87 BLOOD PRESSURE DIASTOLIC ABNORMAL 68 0.0267
88 FOOT DEFORMITY 296 0.0267
89 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 133 0.0262
90 LUNG OPACITY 69 0.0262
91 OSTEOSCLEROSIS 41 0.0260
92 PRESCRIBED OVERDOSE 501 0.0259
93 BLOOD URIC ACID INCREASED 149 0.0258
94 CONTRAINDICATED PRODUCT ADMINISTERED 759 0.0250
95 HYPOPHOSPHATAEMIA 185 0.0250
96 ATTENTION DEFICIT HYPERACTIVITY DISORDER 105 0.0249
97 FOETAL EXPOSURE DURING PREGNANCY 2010 0.0247
98 BREAKTHROUGH PAIN 57 0.0246
99 CEREBROSPINAL FLUID LEAKAGE 45 0.0243
100 TERMINAL INSOMNIA 43 0.0243
101 ACCIDENTAL OVERDOSE 869 0.0237
102 HAND DEFORMITY 311 0.0237
103 PEMPHIGUS 296 0.0237
104 BLOOD PRESSURE SYSTOLIC ABNORMAL 58 0.0234
105 VAGINAL DISCHARGE 234 0.0231
106 ALCOHOL ABUSE 61 0.0228
107 ORAL CANDIDIASIS 300 0.0228
108 WITHDRAWAL SYNDROME 954 0.0227
109 HELICOBACTER INFECTION 231 0.0225
110 HAEMORRHAGIC STROKE 174 0.0223
111 BACK INJURY 239 0.0220
112 AORTIC ARTERIOSCLEROSIS 56 0.0217
113 FIBROMYALGIA 523 0.0215
114 ONYCHOMADESIS 89 0.0212
115 GUN SHOT WOUND 40 0.0211
116 APPENDICITIS 197 0.0211
117 BREAST CANCER STAGE III 134 0.0207
118 DISLOCATION OF VERTEBRA 47 0.0206
119 DEVICE INFUSION ISSUE 51 0.0205
120 LUPUS-LIKE SYNDROME 186 0.0205
121 DEEP VEIN THROMBOSIS POSTOPERATIVE 41 0.0205
122 AORTIC STENOSIS 71 0.0204
123 NEAR DEATH EXPERIENCE 67 0.0203
124 INADEQUATE ANALGESIA 172 0.0202
125 METASTASES TO SPINE 68 0.0202
126 IMPLANT SITE INFECTION 47 0.0202
127 EUPHORIC MOOD 204 0.0199
128 DENTAL CARIES 220 0.0199
129 BRAIN INJURY 199 0.0198
130 HYPERAESTHESIA 160 0.0195
131 MYASTHENIA GRAVIS 157 0.0194
132 MUSCLE INJURY 161 0.0194
133 MAJOR DEPRESSION 140 0.0191
134 TROPONIN INCREASED 145 0.0190
135 TOOTH LOSS 392 0.0189
136 BONE LESION 68 0.0188
137 IMPLANT SITE PAIN 84 0.0188
138 CANCER PAIN 48 0.0188
139 RED CELL DISTRIBUTION WIDTH INCREASED 78 0.0188
140 TENDERNESS 195 0.0187
141 BREATH SOUNDS ABNORMAL 92 0.0186
142 INTERVERTEBRAL DISC DEGENERATION 172 0.0186
143 INJURY 1303 0.0185
144 RESPIRATORY DEPRESSION 227 0.0185
145 NECK INJURY 54 0.0184
146 PERICARDITIS 307 0.0183
147 MONOCYTE COUNT INCREASED 66 0.0182
148 INFUSION RELATED REACTION 1201 0.0181
149 PARAESTHESIA ORAL 260 0.0180
150 HEPATIC CIRRHOSIS 337 0.0179
151 SPINAL OSTEOARTHRITIS 157 0.0179
152 IMPAIRED WORK ABILITY 379 0.0177
153 EXPOSURE DURING PREGNANCY 1091 0.0175
154 FOLLICULITIS 184 0.0175
155 WOUND INFECTION 191 0.0174
156 PHYSICAL DISABILITY 77 0.0174
157 DEATH 14926 0.0173
158 PANCREATITIS CHRONIC 41 0.0173
159 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 291 0.0170
160 VASCULAR DEVICE INFECTION 77 0.0170
161 ROAD TRAFFIC ACCIDENT 705 0.0168
162 NEPHROGENIC ANAEMIA 78 0.0168
163 VENTRICULAR FIBRILLATION 187 0.0168
164 ANXIETY DISORDER 55 0.0164
165 VARICOSE VEIN 85 0.0164
166 CHOLECYSTITIS ACUTE 93 0.0164
167 OEDEMA 887 0.0163
168 SEDATION 423 0.0161
169 BEHAVIOUR DISORDER 87 0.0161
170 OSTEOARTHRITIS 679 0.0160
171 DRUG INTOLERANCE 1547 0.0160
172 C-REACTIVE PROTEIN ABNORMAL 102 0.0159
173 SPINAL FUSION SURGERY 64 0.0158
174 ATELECTASIS 152 0.0157
175 QUALITY OF LIFE DECREASED 210 0.0156
176 BLOOD PRESSURE DIASTOLIC INCREASED 72 0.0156
177 PATHOLOGICAL FRACTURE 79 0.0156
178 LUMBAR SPINAL STENOSIS 45 0.0154
179 ASCITES 452 0.0154
180 WHEEZING 903 0.0152
181 C-REACTIVE PROTEIN INCREASED 549 0.0151
182 NEURALGIA 364 0.0150
183 GLOSSODYNIA 334 0.0149
184 SICKLE CELL ANAEMIA WITH CRISIS 235 0.0149
185 HYPERLIPIDAEMIA 178 0.0149
186 FREQUENT BOWEL MOVEMENTS 401 0.0148
187 OBSTRUCTION 59 0.0148
188 BLOOD PRESSURE DIASTOLIC DECREASED 109 0.0148
189 NERVE INJURY 163 0.0146
190 FAILURE TO THRIVE 76 0.0146
191 WOUND 409 0.0146
192 OBESITY 231 0.0145
193 ORTHOPNOEA 46 0.0144
194 RESPIRATORY SYMPTOM 41 0.0144
195 HYPOPNOEA 50 0.0144
196 BENIGN PROSTATIC HYPERPLASIA 74 0.0143
197 VITAMIN B12 DEFICIENCY 58 0.0143
198 ABDOMINAL HERNIA 65 0.0142
199 SUICIDAL BEHAVIOUR 59 0.0142
200 UNEVALUABLE EVENT 1073 0.0142
201 GENERALISED OEDEMA 175 0.0141
202 UPPER RESPIRATORY TRACT INFECTION 652 0.0141
203 FUNCTIONAL GASTROINTESTINAL DISORDER 48 0.0139
204 PHOTOPHOBIA 261 0.0139
205 MATERNAL EXPOSURE DURING PREGNANCY 1235 0.0138
206 CARDIOGENIC SHOCK 197 0.0137
207 OCULAR DISCOMFORT 154 0.0137
208 HEPATIC ENZYME INCREASED 932 0.0137
209 ANKYLOSING SPONDYLITIS 180 0.0136
210 LEG AMPUTATION 56 0.0136
211 INTERVERTEBRAL DISC DISORDER 58 0.0136
212 ARTHRITIS INFECTIVE 63 0.0136
213 PROCEDURAL PAIN 376 0.0135
214 SPUTUM DISCOLOURED 128 0.0135
215 CHOLECYSTITIS CHRONIC 90 0.0134
216 SPINAL CORD COMPRESSION 52 0.0133
217 LIVE BIRTH 111 0.0133
218 BLOOD PRESSURE SYSTOLIC DECREASED 60 0.0132
219 WOUND DEHISCENCE 44 0.0130
220 MENTAL IMPAIRMENT 313 0.0129
221 BODY TEMPERATURE DECREASED 127 0.0129
222 ENDOCARDITIS 66 0.0129
223 RHEUMATOID ARTHRITIS 1460 0.0128
224 BACTERIAL INFECTION 237 0.0127
225 JOINT RANGE OF MOTION DECREASED 169 0.0126
226 RENAL CYST 100 0.0126
227 MUCOUS STOOLS 62 0.0125
228 UNRESPONSIVE TO STIMULI 322 0.0125
229 ASTHMA 1409 0.0125
230 SMALL INTESTINAL OBSTRUCTION 153 0.0124
231 IMPAIRED DRIVING ABILITY 141 0.0124
232 RESPIRATORY TRACT INFECTION 323 0.0124
233 BLOOD CALCIUM INCREASED 108 0.0123
234 OSTEOPOROSIS 506 0.0123
235 GENERAL PHYSICAL HEALTH DETERIORATION 1421 0.0123
236 LIVER INJURY 301 0.0123
237 ASPIRATION 134 0.0122
238 TOOTH INJURY 53 0.0122
239 DEPRESSION 2777 0.0122
240 JOINT STIFFNESS 320 0.0122
241 SPINAL OPERATION 149 0.0121
242 UMBILICAL HERNIA 56 0.0120
243 WOUND COMPLICATION 41 0.0119
244 FACIAL BONES FRACTURE 43 0.0119
245 ANXIETY 3395 0.0119
246 BLOOD PRESSURE SYSTOLIC INCREASED 232 0.0119
247 TOOTH ABSCESS 121 0.0119
248 ULCER 189 0.0119
249 INTENTIONAL PRODUCT MISUSE 1023 0.0117
250 HAEMORRHAGIC DIATHESIS 41 0.0115
251 TASTE DISORDER 233 0.0115
252 BLOOD ALBUMIN DECREASED 91 0.0115
253 JOINT SWELLING 1382 0.0114
254 LYMPHOEDEMA 79 0.0114
255 INTERVERTEBRAL DISC PROTRUSION 247 0.0113
256 DEPENDENCE 618 0.0113
257 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 797 0.0112
258 COMPRESSION FRACTURE 60 0.0112
259 NEPHROLITHIASIS 511 0.0111
260 BRONCHIECTASIS 75 0.0111
261 HYPERHIDROSIS 1433 0.0111
262 METASTASES TO LYMPH NODES 75 0.0111
263 PANIC DISORDER 43 0.0111
264 AMNESIA 722 0.0111
265 SPINAL DISORDER 105 0.0111
266 AUTOIMMUNE DISORDER 108 0.0111
267 PERIPHERAL VASCULAR DISORDER 57 0.0111
268 IMPAIRED QUALITY OF LIFE 159 0.0110
269 MENTAL STATUS CHANGES 306 0.0110
270 PERSONALITY CHANGE 102 0.0110
271 ALCOHOLISM 47 0.0110
272 END STAGE RENAL DISEASE 199 0.0109
273 SOCIAL AVOIDANT BEHAVIOUR 63 0.0109
274 BLOOD CHOLESTEROL INCREASED 505 0.0108
275 THERAPEUTIC PRODUCT EFFECT DECREASED 485 0.0108
276 SPINAL COLUMN STENOSIS 51 0.0108
277 MALNUTRITION 120 0.0107
278 COMMUNICATION DISORDER 41 0.0107
279 SPINAL STENOSIS 44 0.0106
280 CARDIOMEGALY 131 0.0106
281 IRRITABLE BOWEL SYNDROME 222 0.0103
282 NECK PAIN 578 0.0103
283 HEAD DISCOMFORT 183 0.0103
284 SCOLIOSIS 64 0.0103
285 ORAL PAIN 231 0.0103
286 RASH ERYTHEMATOUS 493 0.0103
287 DECREASED IMMUNE RESPONSIVENESS 101 0.0103
288 ARTERIOSCLEROSIS CORONARY ARTERY 68 0.0103
289 RESPIRATORY RATE INCREASED 91 0.0102
290 COLITIS 387 0.0102
291 LIVER FUNCTION TEST INCREASED 219 0.0102
292 CARDIAC DISORDER 952 0.0102
293 FLANK PAIN 95 0.0101
294 BIPOLAR DISORDER 110 0.0101
295 RIB FRACTURE 207 0.0101
296 DEFORMITY 94 0.0100
297 OSTEOMYELITIS 182 0.0100
298 IMPAIRED HEALING 329 0.0100
299 COMA 476 0.0100
300 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 480 0.0100
301 CONSTIPATION 2176 0.0100
302 TYPE 2 DIABETES MELLITUS 335 0.0099
303 HEPATIC LESION 43 0.0099
304 HYPOVOLAEMIA 58 0.0099
305 ALTERED STATE OF CONSCIOUSNESS 214 0.0099
306 ARTHRITIS 777 0.0099
307 GROIN PAIN 86 0.0098
308 SLEEP APNOEA SYNDROME 186 0.0097
309 RECTAL HAEMORRHAGE 417 0.0097
310 MULTIPLE MYELOMA 45 0.0096
311 ABSCESS LIMB 41 0.0096
312 GAIT INABILITY 321 0.0096
313 MUSCULOSKELETAL PAIN 501 0.0096
314 PARONYCHIA 42 0.0095
315 SLEEP DISORDER 674 0.0095
316 ABDOMINAL PAIN 2209 0.0095
317 POST PROCEDURAL INFECTION 77 0.0095
318 PARANOIA 163 0.0094
319 PERFORMANCE STATUS DECREASED 44 0.0094
320 THINKING ABNORMAL 175 0.0094
321 SYSTEMIC LUPUS ERYTHEMATOSUS 333 0.0094
322 PURULENT DISCHARGE 40 0.0094
323 GOUT 168 0.0094
324 PSYCHIATRIC SYMPTOM 69 0.0093
325 LEFT VENTRICULAR HYPERTROPHY 40 0.0093
326 SEPSIS 1042 0.0093
327 BLOOD TEST ABNORMAL 131 0.0093
328 FLUID RETENTION 474 0.0093
329 LUNG INFILTRATION 82 0.0093
330 CLOSTRIDIUM DIFFICILE COLITIS 98 0.0092
331 NO THERAPEUTIC RESPONSE 112 0.0092
332 EAR INFECTION 244 0.0092
333 MULTIPLE ORGAN DYSFUNCTION SYNDROME 259 0.0091
334 RALES 53 0.0091
335 NIGHT SWEATS 294 0.0091
336 HYPOXIA 320 0.0091
337 SPINAL COMPRESSION FRACTURE 75 0.0091
338 WHEELCHAIR USER 40 0.0090
339 NERVE COMPRESSION 83 0.0090
340 DECREASED INTEREST 53 0.0090
341 PROCTALGIA 57 0.0089
342 BLOOD PRESSURE FLUCTUATION 212 0.0088
343 SCIATICA 140 0.0088
344 SCAR 150 0.0088
345 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 457 0.0087
346 HAEMATEMESIS 222 0.0087
347 NIGHTMARE 302 0.0087
348 DECUBITUS ULCER 71 0.0087
349 ODYNOPHAGIA 52 0.0087
350 JOINT EFFUSION 60 0.0087
351 EAR PAIN 168 0.0086
352 POSTOPERATIVE WOUND INFECTION 58 0.0086
353 DRUG USE DISORDER 72 0.0086
354 INFECTION 1238 0.0085
355 FULL BLOOD COUNT ABNORMAL 90 0.0085
356 VAGINAL INFECTION 40 0.0085
357 DYSPHORIA 43 0.0085
358 ANKLE FRACTURE 131 0.0085
359 ABDOMINAL TENDERNESS 42 0.0084
360 TENDON DISORDER 55 0.0084
361 BACK PAIN 1955 0.0084
362 GALLBLADDER DISORDER 150 0.0084
363 MUSCLE SPASTICITY 103 0.0084
364 CEREBRAL DISORDER 62 0.0084
365 INTESTINAL OBSTRUCTION 315 0.0083
366 SPINAL FRACTURE 167 0.0083
367 MUSCULOSKELETAL STIFFNESS 730 0.0083
368 CHOLECYSTECTOMY 95 0.0083
369 DRUG ABUSER 51 0.0083
370 APPETITE DISORDER 55 0.0083
371 PULMONARY EMBOLISM 783 0.0082
372 FOOT FRACTURE 156 0.0082
373 PSYCHOLOGICAL TRAUMA 71 0.0082
374 INCOHERENT 53 0.0082
375 GRIP STRENGTH DECREASED 72 0.0082
376 TREATMENT FAILURE 677 0.0082
377 CACHEXIA 42 0.0082
378 SUICIDAL IDEATION 746 0.0081
379 METASTASES TO CENTRAL NERVOUS SYSTEM 105 0.0081
380 BONE DISORDER 148 0.0081
381 PSORIATIC ARTHROPATHY 328 0.0081
382 SUICIDE ATTEMPT 489 0.0081
383 WALKING AID USER 53 0.0080
384 RESPIRATORY ARREST 221 0.0080
385 TOOTH DISORDER 178 0.0080
386 BLOOD MAGNESIUM DECREASED 69 0.0080
387 MIOSIS 64 0.0080
388 HIP SURGERY 43 0.0079
389 EMPHYSEMA 80 0.0079
390 HAEMATOCHEZIA 437 0.0079
391 POST PROCEDURAL COMPLICATION 152 0.0079
392 PULMONARY MASS 117 0.0078
393 HYPONATRAEMIA 442 0.0078
394 BRAIN OEDEMA 99 0.0078
395 APNOEA 61 0.0078
396 PHLEBITIS 40 0.0078
397 NEUTROPHIL COUNT INCREASED 80 0.0078
398 METASTASES TO BONE 128 0.0078
399 COLITIS ULCERATIVE 348 0.0078
400 MULTIPLE INJURIES 49 0.0078
401 ABSCESS 124 0.0078
402 KIDNEY INFECTION 152 0.0077
403 PULMONARY CONGESTION 102 0.0077
404 CELLULITIS 389 0.0077
405 ARTHROPATHY 429 0.0077
406 DISCOMFORT 470 0.0077
407 DELIRIUM 267 0.0077
408 PNEUMONIA ASPIRATION 192 0.0077
409 SPINAL PAIN 90 0.0077
410 VOMITING 3601 0.0077
411 ANGER 259 0.0077
412 DIPLOPIA 197 0.0076
413 BOWEL MOVEMENT IRREGULARITY 58 0.0076
414 METASTASES TO LIVER 133 0.0076
415 IMPAIRED GASTRIC EMPTYING 103 0.0075
416 DEVICE FAILURE 115 0.0075
417 GASTROOESOPHAGEAL REFLUX DISEASE 608 0.0075
418 STAPHYLOCOCCAL INFECTION 249 0.0075
419 JOINT INJURY 161 0.0075
420 ACCIDENT 90 0.0075
421 MOBILITY DECREASED 541 0.0075
422 TOOTH FRACTURE 83 0.0075
423 MICTURITION URGENCY 86 0.0075
424 PLEURAL EFFUSION 457 0.0075
425 MUSCULOSKELETAL CHEST PAIN 116 0.0075
426 LOWER LIMB FRACTURE 144 0.0075
427 LIP DRY 68 0.0075
428 HYDRONEPHROSIS 56 0.0075
429 FISTULA 84 0.0075
430 ARTERIOSCLEROSIS 70 0.0074
431 LIVER FUNCTION TEST ABNORMAL 216 0.0074
432 HAEMATOCRIT DECREASED 147 0.0074
433 EPILEPSY 226 0.0074
434 PRODUCT PRESCRIBING ISSUE 161 0.0074
435 OEDEMA PERIPHERAL 897 0.0074
436 MENINGITIS 49 0.0073
437 ADRENAL INSUFFICIENCY 89 0.0073
438 BACTERAEMIA 87 0.0073
439 PELVIC FRACTURE 57 0.0073
440 TRICUSPID VALVE INCOMPETENCE 58 0.0073
441 LIMB INJURY 198 0.0073
442 CANDIDA INFECTION 123 0.0073
443 RENAL FAILURE CHRONIC 56 0.0073
444 HYPOAESTHESIA 1087 0.0073
445 OSTEOPENIA 110 0.0072
446 HERPES ZOSTER 416 0.0072
447 PNEUMONIA 2341 0.0072
448 APHTHOUS ULCER 56 0.0072
449 DRUG SCREEN POSITIVE 57 0.0072
450 HYPERTENSION 1525 0.0072
451 ENTERITIS 46 0.0072
452 MIGRAINE 685 0.0072
453 SKIN LACERATION 78 0.0072
454 SEXUAL DYSFUNCTION 84 0.0072
455 PRESYNCOPE 174 0.0071
456 PYELONEPHRITIS 62 0.0071
457 ECCHYMOSIS 49 0.0071
458 DEVICE RELATED INFECTION 110 0.0071
459 STOMATITIS 433 0.0071
460 AFFECTIVE DISORDER 56 0.0071
461 HEREDITARY ANGIOEDEMA 76 0.0071
462 LIGAMENT SPRAIN 70 0.0071
463 RESPIRATORY DISORDER 211 0.0070
464 DRY MOUTH 572 0.0070
465 EATING DISORDER 150 0.0070
466 SOMNOLENCE 1417 0.0070
467 DIVERTICULUM 50 0.0070
468 CHOLELITHIASIS 230 0.0070
469 LUNG DISORDER 343 0.0070
470 MUSCULOSKELETAL DISCOMFORT 120 0.0070
471 BREAST CANCER STAGE II 58 0.0070
472 CARDIO-RESPIRATORY ARREST 290 0.0069
473 IRON DEFICIENCY ANAEMIA 64 0.0069
474 WRIST FRACTURE 83 0.0069
475 THERMAL BURN 49 0.0069
476 SWELLING 644 0.0069
477 POOR VENOUS ACCESS 71 0.0069
478 NAIL DISORDER 60 0.0069
479 RESPIRATORY DISTRESS 188 0.0068
480 HAEMATURIA 233 0.0068
481 BREAST CANCER METASTATIC 73 0.0068
482 HIP ARTHROPLASTY 104 0.0068
483 CONCUSSION 52 0.0067
484 MYOCLONUS 80 0.0067
485 INFLAMMATION 346 0.0067
486 BLINDNESS 273 0.0067
487 ILEUS 83 0.0067
488 DEEP VEIN THROMBOSIS 433 0.0067
489 WEIGHT DECREASED 1855 0.0066
490 HYPERCALCAEMIA 82 0.0066
491 HALLUCINATION 498 0.0066
492 PYREXIA 2283 0.0066
493 ABNORMAL FAECES 54 0.0066
494 CHOLECYSTITIS 78 0.0065
495 BRONCHITIS 482 0.0065
496 ULCER HAEMORRHAGE 44 0.0065
497 THROMBOCYTOPENIA 727 0.0065
498 PELVIC PAIN 118 0.0065
499 ROTATOR CUFF SYNDROME 83 0.0065
500 VITAMIN D DEFICIENCY 63 0.0065
501 PRODUCTIVE COUGH 308 0.0064
502 BLOOD TESTOSTERONE DECREASED 44 0.0064
503 BLISTER 361 0.0064
504 INTENTIONAL PRODUCT USE ISSUE 563 0.0064
505 HYPERSENSITIVITY 1192 0.0064
506 LEUKOCYTOSIS 116 0.0064
507 HAEMORRHOIDS 125 0.0064
508 MOOD SWINGS 204 0.0064
509 BACK DISORDER 104 0.0064
510 HYPOKALAEMIA 294 0.0064
511 ANAEMIA 1206 0.0063
512 SPLENOMEGALY 74 0.0063
513 BEDRIDDEN 83 0.0063
514 CYSTITIS 201 0.0063
515 PANIC ATTACK 230 0.0063
516 TACHYCARDIA 559 0.0063
517 SECOND PRIMARY MALIGNANCY 52 0.0062
518 LOCALISED INFECTION 151 0.0062
519 CARDIAC MURMUR 54 0.0062
520 ACUTE RESPIRATORY FAILURE 120 0.0062
521 KNEE ARTHROPLASTY 131 0.0062
522 TOOTH INFECTION 82 0.0062
523 PRODUCT PRESCRIBING ERROR 148 0.0062
524 MITRAL VALVE INCOMPETENCE 70 0.0062
525 BLOOD CALCIUM DECREASED 69 0.0061
526 CONFUSIONAL STATE 990 0.0061
527 RENAL TUBULAR NECROSIS 60 0.0061
528 SKIN ULCER 158 0.0061
529 OXYGEN SATURATION DECREASED 343 0.0061
530 OVARIAN CYST 61 0.0061
531 DYSPEPSIA 599 0.0061
532 NAUSEA 4811 0.0061
533 TOOTHACHE 110 0.0061
534 FEBRILE NEUTROPENIA 403 0.0061
535 ABDOMINAL DISTENSION 630 0.0060
536 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 102 0.0060
537 COGNITIVE DISORDER 280 0.0060
538 PANCREATITIS 315 0.0060
539 BLOOD PRESSURE INCREASED 911 0.0060
540 HIATUS HERNIA 77 0.0059
541 ORAL HERPES 116 0.0059
542 BODY TEMPERATURE INCREASED 121 0.0059
543 DECREASED APPETITE 1377 0.0059
544 GASTROINTESTINAL PAIN 65 0.0059
545 ANHEDONIA 155 0.0059
546 INCONTINENCE 62 0.0059
547 DEHYDRATION 782 0.0059
548 OESOPHAGITIS 64 0.0059
549 HEPATIC STEATOSIS 109 0.0058
550 PULMONARY FIBROSIS 112 0.0058
551 WEIGHT FLUCTUATION 61 0.0058
552 UPPER-AIRWAY COUGH SYNDROME 48 0.0058
553 CHEST PAIN 1079 0.0058
554 PERIPHERAL SWELLING 897 0.0058
555 ECONOMIC PROBLEM 88 0.0058
556 PHARYNGITIS 72 0.0058
557 MALIGNANT NEOPLASM PROGRESSION 594 0.0058
558 LEUKOPENIA 290 0.0058
559 MASS 81 0.0058
560 HAND FRACTURE 41 0.0058
561 ANAL INCONTINENCE 52 0.0058
562 RETCHING 123 0.0058
563 CHILLS 676 0.0058
564 SURGERY 336 0.0057
565 HYPERSOMNIA 164 0.0057
566 RESPIRATORY FAILURE 416 0.0057
567 SINUS TACHYCARDIA 81 0.0057
568 SCRATCH 60 0.0057
569 HYPOPHAGIA 145 0.0057
570 GASTRITIS 149 0.0057
571 CARPAL TUNNEL SYNDROME 79 0.0056
572 LETHARGY 323 0.0056
573 SENSORY LOSS 45 0.0056
574 NEOPLASM PROGRESSION 194 0.0056
575 ARTHRALGIA 2316 0.0056
576 URINARY RETENTION 185 0.0055
577 METASTASES TO LUNG 64 0.0055
578 TEMPERATURE INTOLERANCE 57 0.0055
579 HEART RATE DECREASED 193 0.0055
580 LIPASE INCREASED 42 0.0055
581 ILLNESS 564 0.0055
582 MEMORY IMPAIRMENT 751 0.0055
583 ABDOMINAL PAIN UPPER 1122 0.0054
584 CORONARY ARTERY DISEASE 164 0.0054
585 DYSURIA 199 0.0054
586 HYPOALBUMINAEMIA 42 0.0054
587 PNEUMONITIS 147 0.0054
588 WHITE BLOOD CELL COUNT INCREASED 207 0.0054
589 HEPATOMEGALY 53 0.0054
590 BLOOD POTASSIUM DECREASED 162 0.0054
591 IMMUNE SYSTEM DISORDER 71 0.0054
592 LOWER RESPIRATORY TRACT INFECTION 245 0.0054
593 INSOMNIA 1434 0.0054
594 MALAISE 2356 0.0054
595 DYSARTHRIA 202 0.0054
596 GASTROINTESTINAL INFLAMMATION 42 0.0054
597 SKIN LESION 147 0.0054
598 OBSESSIVE-COMPULSIVE DISORDER 43 0.0054
599 BLOOD ALKALINE PHOSPHATASE INCREASED 133 0.0054
600 LOSS OF CONSCIOUSNESS 685 0.0053
601 ABDOMINAL PAIN LOWER 135 0.0053
602 ABDOMINAL DISCOMFORT 895 0.0053
603 BLOOD UREA INCREASED 89 0.0053
604 CLOSTRIDIUM DIFFICILE INFECTION 116 0.0053
605 TINNITUS 243 0.0053
606 GASTROENTERITIS 77 0.0053
607 HEPATIC FAILURE 159 0.0053
608 FALL 1754 0.0053
609 BONE PAIN 308 0.0053
610 THROMBOSIS 423 0.0053
611 PRODUCT USE ISSUE 986 0.0052
612 RESTLESSNESS 192 0.0052
613 MYOSITIS 47 0.0052
614 CYST 65 0.0052
615 MOUTH ULCERATION 110 0.0052
616 MUSCLE ATROPHY 66 0.0052
617 MUSCLE STRAIN 45 0.0052
618 DISTURBANCE IN ATTENTION 280 0.0052
619 LIVER DISORDER 230 0.0052
620 GASTROINTESTINAL DISORDER 464 0.0052
621 OSTEONECROSIS OF JAW 128 0.0052
622 SKIN INFECTION 58 0.0052
623 VISUAL IMPAIRMENT 640 0.0052
624 HEAD INJURY 163 0.0051
625 URINE OUTPUT DECREASED 45 0.0051
626 HEART RATE IRREGULAR 116 0.0051
627 OBSTRUCTIVE AIRWAYS DISORDER 57 0.0051
628 LYMPHADENOPATHY 181 0.0051
629 PNEUMOTHORAX 81 0.0051
630 HYPOMAGNESAEMIA 71 0.0051
631 MUSCULAR WEAKNESS 579 0.0051
632 COORDINATION ABNORMAL 71 0.0051
633 ANAPHYLACTIC REACTION 281 0.0051
634 COLD SWEAT 89 0.0050
635 FACIAL PAIN 45 0.0050
636 SINUS DISORDER 99 0.0050
637 SWOLLEN TONGUE 156 0.0050
638 CONTUSION 477 0.0049
639 BLOOD CREATININE INCREASED 323 0.0049
640 PAIN IN JAW 140 0.0049
641 PAIN IN EXTREMITY 1455 0.0049
642 DIABETES MELLITUS 376 0.0049
643 CRYING 179 0.0049
644 HOSPITALISATION 752 0.0049
645 HEADACHE 3067 0.0049
646 BLOOD IRON DECREASED 58 0.0049
647 BLOOD BILIRUBIN INCREASED 132 0.0049
648 APHASIA 147 0.0049
649 URINARY INCONTINENCE 144 0.0049
650 HAEMOPTYSIS 135 0.0048
651 DYSSTASIA 141 0.0048
652 PARALYSIS 69 0.0048
653 EMBOLISM 40 0.0048
654 DYSPNOEA 2719 0.0048
655 AGGRESSION 240 0.0048
656 DISORIENTATION 190 0.0048
657 ERECTILE DYSFUNCTION 123 0.0048
658 BREAST PAIN 51 0.0048
659 HEART RATE INCREASED 473 0.0048
660 UPPER LIMB FRACTURE 95 0.0048
661 RED BLOOD CELL COUNT DECREASED 136 0.0048
662 FEMUR FRACTURE 147 0.0047
663 BLADDER DISORDER 47 0.0047
664 FEAR 127 0.0047
665 ASTHENIA 1774 0.0047
666 ERYTHEMA 965 0.0047
667 FATIGUE 3652 0.0047
668 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 257 0.0047
669 SEIZURE 536 0.0046
670 DELUSION 72 0.0046
671 MUSCLE SPASMS 846 0.0046
672 DIARRHOEA HAEMORRHAGIC 43 0.0046
673 GLAUCOMA 87 0.0045
674 RESTLESS LEGS SYNDROME 82 0.0045
675 EMOTIONAL DISORDER 139 0.0045
676 PSYCHOTIC DISORDER 133 0.0045
677 SUPRAVENTRICULAR TACHYCARDIA 43 0.0045
678 BODY HEIGHT DECREASED 48 0.0045
679 DYSPHAGIA 426 0.0045
680 DEPRESSED LEVEL OF CONSCIOUSNESS 176 0.0044
681 HIP FRACTURE 143 0.0044
682 RENAL FAILURE 590 0.0044
683 PULMONARY OEDEMA 198 0.0044
684 HAEMOGLOBIN DECREASED 454 0.0044
685 TOOTH EXTRACTION 55 0.0044
686 ADVERSE DRUG REACTION 396 0.0044
687 SKIN DISORDER 147 0.0044
688 TREMOR 731 0.0044
689 SECRETION DISCHARGE 55 0.0044
690 GAIT DISTURBANCE 837 0.0044
691 AFFECT LABILITY 42 0.0044
692 EYE PAIN 246 0.0044
693 TACHYPNOEA 59 0.0043
694 CARDIOMYOPATHY 64 0.0043
695 FLUID OVERLOAD 63 0.0043
696 BURNING SENSATION 303 0.0043
697 ABNORMAL BEHAVIOUR 171 0.0043
698 SYNCOPE 431 0.0043
699 ELECTROLYTE IMBALANCE 50 0.0043
700 DYSPNOEA EXERTIONAL 162 0.0043
701 LYMPHOCYTE COUNT DECREASED 76 0.0043
702 NEUROTOXICITY 75 0.0043
703 LIMB DISCOMFORT 132 0.0043
704 SINUSITIS 434 0.0042
705 RENAL FAILURE ACUTE 179 0.0042
706 NASAL CONGESTION 247 0.0042
707 COAGULOPATHY 69 0.0041
708 GASTRIC DISORDER 142 0.0041
709 LACRIMATION INCREASED 125 0.0041
710 HYPOKINESIA 60 0.0041
711 TRANSIENT ISCHAEMIC ATTACK 139 0.0041
712 NASOPHARYNGITIS 756 0.0041
713 INTESTINAL PERFORATION 46 0.0041
714 HALLUCINATION, AUDITORY 65 0.0041
715 NEOPLASM 47 0.0041
716 CONDITION AGGRAVATED 1240 0.0041
717 FEELING HOT 250 0.0041
718 LOCAL SWELLING 71 0.0041
719 FRACTURE 77 0.0041
720 ILL-DEFINED DISORDER 247 0.0041
721 TRANSAMINASES INCREASED 90 0.0040
722 ACTIVITIES OF DAILY LIVING IMPAIRED 80 0.0040
723 RHINORRHOEA 261 0.0040
724 CARDIAC ARREST 333 0.0040
725 URINARY TRACT INFECTION 686 0.0040
726 PALLOR 109 0.0040
727 NERVOUS SYSTEM DISORDER 125 0.0040
728 EJECTION FRACTION DECREASED 62 0.0040
729 OFF LABEL USE 3489 0.0040
730 EYE DISORDER 131 0.0040
731 HERNIA 77 0.0040
732 PARAESTHESIA 626 0.0040
733 HYPOTENSION 796 0.0040
734 COUGH 1110 0.0040
735 DEPRESSED MOOD 209 0.0039
736 DRUG-INDUCED LIVER INJURY 124 0.0039
737 POST PROCEDURAL HAEMORRHAGE 46 0.0039
738 PLASMA CELL MYELOMA 154 0.0039
739 CYANOSIS 62 0.0039
740 MULTI-ORGAN FAILURE 68 0.0039
741 RENAL DISORDER 183 0.0039
742 BLOOD SODIUM DECREASED 74 0.0039
743 ABASIA 97 0.0039
744 COMPLICATION ASSOCIATED WITH DEVICE 57 0.0039
745 NEUROPATHY PERIPHERAL 372 0.0039
746 NODULE 51 0.0039
747 PERICARDIAL EFFUSION 90 0.0039
748 WEIGHT INCREASED 871 0.0039
749 HYPOTHYROIDISM 124 0.0039
750 PHARYNGITIS STREPTOCOCCAL 42 0.0039
751 PHOTOSENSITIVITY REACTION 64 0.0039
752 APHONIA 54 0.0039
753 GASTRIC ULCER 73 0.0038
754 DIARRHOEA 2475 0.0038
755 PETECHIAE 40 0.0038
756 ASPARTATE AMINOTRANSFERASE INCREASED 203 0.0038
757 CHRONIC KIDNEY DISEASE 290 0.0038
758 LUNG INFECTION 59 0.0038
759 PULMONARY HYPERTENSION 79 0.0038
760 PERIPHERAL COLDNESS 52 0.0038
761 HAEMATOMA 98 0.0038
762 THERAPEUTIC RESPONSE DECREASED 229 0.0038
763 PULMONARY THROMBOSIS 41 0.0038
764 POLYNEUROPATHY 45 0.0038
765 MOVEMENT DISORDER 120 0.0037
766 SKIN FISSURES 73 0.0037
767 DIZZINESS 1852 0.0037
768 BLOOD PRESSURE DECREASED 246 0.0037
769 SEPTIC SHOCK 161 0.0037
770 WRONG TECHNIQUE IN DRUG USAGE PROCESS 134 0.0037
771 GINGIVAL BLEEDING 50 0.0037
772 DYSPHONIA 214 0.0037
773 FEEDING DISORDER 74 0.0036
774 PSORIASIS 476 0.0036
775 COVID-19 PNEUMONIA 43 0.0036
776 CARDIOVASCULAR DISORDER 92 0.0036
777 THERAPY NON-RESPONDER 162 0.0036
778 BLOOD LACTATE DEHYDROGENASE INCREASED 57 0.0036
779 DISEASE PROGRESSION 424 0.0036
780 PRESCRIBED UNDERDOSE 71 0.0036
781 GASTROENTERITIS VIRAL 64 0.0035
782 DIVERTICULITIS 98 0.0035
783 PANCYTOPENIA 197 0.0035
784 SWELLING FACE 229 0.0035
785 PRODUCT USE IN UNAPPROVED INDICATION 868 0.0035
786 ACUTE KIDNEY INJURY 535 0.0035
787 DERMATITIS 73 0.0035
788 RESPIRATORY TRACT CONGESTION 55 0.0035
789 NOCTURIA 42 0.0035
790 FAECES DISCOLOURED 75 0.0035
791 AGITATION 254 0.0035
792 DRUG INEFFECTIVE 4543 0.0034
793 MOOD ALTERED 94 0.0034
794 ANGIOEDEMA 152 0.0034
795 RASH 1491 0.0034
796 INFUSION SITE PAIN 44 0.0034
797 DEVICE OCCLUSION 48 0.0034
798 TENDON RUPTURE 42 0.0034
799 BALANCE DISORDER 294 0.0034
800 OROPHARYNGEAL PAIN 314 0.0034
801 POOR QUALITY SLEEP 73 0.0034
802 CYTOKINE RELEASE SYNDROME 68 0.0034
803 SEROTONIN SYNDROME 65 0.0034
804 MYALGIA 575 0.0034
805 JAUNDICE 91 0.0034
806 BLOOD URINE PRESENT 64 0.0034
807 HALLUCINATION, VISUAL 71 0.0034
808 PANCREATITIS ACUTE 75 0.0033
809 MUSCLE TIGHTNESS 54 0.0033
810 SINUS CONGESTION 45 0.0033
811 PLATELET COUNT INCREASED 43 0.0033
812 PREMATURE BABY 99 0.0033
813 ANGINA PECTORIS 94 0.0033
814 FUNGAL INFECTION 109 0.0033
815 PROTEINURIA 62 0.0033
816 NERVOUSNESS 170 0.0033
817 ENCEPHALOPATHY 79 0.0032
818 ORTHOSTATIC HYPOTENSION 56 0.0032
819 ATRIAL FIBRILLATION 313 0.0032
820 COMPLETED SUICIDE 267 0.0032
821 BLOOD POTASSIUM INCREASED 52 0.0032
822 BONE LOSS 48 0.0032
823 DERMATITIS ALLERGIC 40 0.0032
824 SKIN DISCOLOURATION 146 0.0032
825 MUCOSAL INFLAMMATION 83 0.0032
826 SPEECH DISORDER 166 0.0032
827 FEELING ABNORMAL 759 0.0032
828 SUBDURAL HAEMATOMA 45 0.0031
829 ALANINE AMINOTRANSFERASE INCREASED 193 0.0031
830 DRUG PRESCRIBING ERROR 60 0.0031
831 ACUTE RESPIRATORY DISTRESS SYNDROME 55 0.0031
832 TENDONITIS 48 0.0031
833 CARDIAC FAILURE CONGESTIVE 246 0.0031
834 DEMENTIA 85 0.0030
835 MUSCLE TWITCHING 70 0.0030
836 INTENTIONAL SELF-INJURY 61 0.0030
837 FEELING COLD 84 0.0030
838 APATHY 44 0.0030
839 DRUG TOXICITY 41 0.0030
840 INFLUENZA LIKE ILLNESS 247 0.0030
841 VISION BLURRED 410 0.0030
842 CHEST DISCOMFORT 305 0.0030
843 DYSKINESIA 121 0.0030
844 NEUTROPHIL COUNT DECREASED 121 0.0030
845 BLOOD COUNT ABNORMAL 45 0.0030
846 IRRITABILITY 178 0.0030
847 INFLUENZA 329 0.0029
848 UVEITIS 40 0.0029
849 DRUG EFFECT DECREASED 158 0.0029
850 RENAL IMPAIRMENT 246 0.0029
851 INTERNATIONAL NORMALISED RATIO INCREASED 83 0.0029
852 URTICARIA 487 0.0029
853 HYPOCALCAEMIA 55 0.0029
854 VERTIGO 177 0.0029
855 POLLAKIURIA 121 0.0029
856 HEMIPARESIS 49 0.0029
857 OSTEONECROSIS 95 0.0029
858 MEDICATION ERROR 160 0.0029
859 THROAT IRRITATION 129 0.0029
860 SENSORY DISTURBANCE 46 0.0029
861 FLATULENCE 162 0.0029
862 SNEEZING 64 0.0029
863 HYPOAESTHESIA ORAL 43 0.0028
864 PLATELET COUNT DECREASED 303 0.0028
865 GENERALISED TONIC-CLONIC SEIZURE 47 0.0028
866 EPISTAXIS 212 0.0028
867 ALOPECIA 552 0.0028
868 UPPER GASTROINTESTINAL HAEMORRHAGE 47 0.0028
869 HYPOACUSIS 120 0.0028
870 TREATMENT NONCOMPLIANCE 151 0.0028
871 CONVULSION 157 0.0027
872 HYPERGLYCAEMIA 100 0.0027
873 MULTIPLE FRACTURES 45 0.0027
874 VIRAL INFECTION 91 0.0027
875 DEAFNESS 71 0.0027
876 HYPERKALAEMIA 95 0.0027
877 RENAL INJURY 80 0.0027
878 CATARACT 160 0.0027
879 COLON CANCER 40 0.0027
880 GASTROINTESTINAL HAEMORRHAGE 224 0.0027
881 INJECTION SITE MASS 99 0.0027
882 INCREASED APPETITE 51 0.0027
883 HOT FLUSH 201 0.0027
884 THYROID DISORDER 41 0.0027
885 PRURITUS 1012 0.0026
886 PRODUCT ADHESION ISSUE 94 0.0026
887 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 472 0.0026
888 DRUG INTERACTION 412 0.0026
889 WHITE BLOOD CELL COUNT DECREASED 281 0.0026
890 HYPOGLYCAEMIA 125 0.0026
891 SHOCK 59 0.0026
892 CARDIAC FAILURE 204 0.0025
893 INJECTION SITE WARMTH 52 0.0025
894 CHROMATURIA 57 0.0025
895 ACUTE MYOCARDIAL INFARCTION 74 0.0025
896 LABORATORY TEST ABNORMAL 74 0.0025
897 PANCREATIC CARCINOMA 71 0.0025
898 TUBULOINTERSTITIAL NEPHRITIS 46 0.0025
899 ARRHYTHMIA 115 0.0024
900 VENTRICULAR TACHYCARDIA 40 0.0024
901 DRY EYE 119 0.0024
902 BLOOD PRESSURE ABNORMAL 47 0.0024
903 BONE MARROW FAILURE 48 0.0024
904 DIABETES MELLITUS INADEQUATE CONTROL 41 0.0023
905 INTERSTITIAL LUNG DISEASE 112 0.0023
906 CEREBROVASCULAR ACCIDENT 391 0.0023
907 ADVERSE EVENT 212 0.0023
908 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 52 0.0022
909 HEPATITIS 57 0.0022
910 PALPITATIONS 259 0.0022
911 UNDERDOSE 161 0.0022
912 DRUG EFFECT INCOMPLETE 79 0.0022
913 MUSCULOSKELETAL DISORDER 41 0.0022
914 GAMMA-GLUTAMYLTRANSFERASE INCREASED 47 0.0021
915 ERUCTATION 41 0.0021
916 LUNG NEOPLASM MALIGNANT 87 0.0021
917 MYOCARDIAL INFARCTION 366 0.0021
918 PREGNANCY 42 0.0021
919 THROAT TIGHTNESS 56 0.0021
920 CHOKING 40 0.0020
921 NEUTROPENIA 276 0.0020
922 NEOPLASM MALIGNANT 134 0.0020
923 MELAENA 44 0.0020
924 PRURITUS GENERALISED 43 0.0020
925 DRUG ADMINISTRATION ERROR 61 0.0020
926 DEVICE DISLOCATION 86 0.0020
927 PRODUCT QUALITY ISSUE 268 0.0020
928 METABOLIC ACIDOSIS 63 0.0020
929 THERAPEUTIC RESPONSE SHORTENED 65 0.0020
930 GLYCOSYLATED HAEMOGLOBIN INCREASED 49 0.0019
931 HEPATOTOXICITY 43 0.0019
932 HAEMORRHAGE 200 0.0019
933 PHARMACEUTICAL PRODUCT COMPLAINT 49 0.0019
934 ABNORMAL DREAMS 52 0.0019
935 FLUSHING 190 0.0019
936 ELECTROCARDIOGRAM QT PROLONGED 66 0.0018
937 BLOOD GLUCOSE DECREASED 88 0.0018
938 ECZEMA 94 0.0018
939 DEVICE ISSUE 161 0.0018
940 RASH PRURITIC 96 0.0018
941 DYSGEUSIA 131 0.0018
942 NEEDLE ISSUE 51 0.0018
943 BLOOD CREATINE PHOSPHOKINASE INCREASED 50 0.0017
944 MULTIPLE SCLEROSIS 83 0.0017
945 ABORTION SPONTANEOUS 69 0.0017
946 THERAPEUTIC RESPONSE UNEXPECTED 77 0.0017
947 BRADYCARDIA 91 0.0017
948 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 122 0.0017
949 COVID-19 288 0.0016
950 DIABETIC KETOACIDOSIS 39 0.0016
951 RASH MACULAR 56 0.0016
952 ANAPHYLACTIC SHOCK 41 0.0016
953 PAIN OF SKIN 42 0.0016
954 OCULAR HYPERAEMIA 73 0.0015
955 CEREBRAL HAEMORRHAGE 55 0.0015
956 DEVICE MALFUNCTION 107 0.0015
957 EYE SWELLING 56 0.0015
958 APPLICATION SITE ERYTHEMA 39 0.0015
959 BONE DENSITY DECREASED 45 0.0014
960 INCORRECT DOSE ADMINISTERED 318 0.0014
961 BLOOD GLUCOSE INCREASED 260 0.0014
962 INJECTION SITE REACTION 94 0.0014
963 DRY SKIN 181 0.0014
964 LIP SWELLING 45 0.0013
965 SKIN EXFOLIATION 114 0.0013
966 INTENTIONAL OVERDOSE 86 0.0013
967 DRUG DOSE OMISSION 218 0.0013
968 RHABDOMYOLYSIS 54 0.0013
969 INCORRECT ROUTE OF DRUG ADMINISTRATION 44 0.0012
970 PRODUCT DOSE OMISSION ISSUE 357 0.0012
971 VAGINAL HAEMORRHAGE 52 0.0012
972 THERAPY CESSATION 59 0.0011
973 DEVICE LEAKAGE 49 0.0011
974 BREAST CANCER 100 0.0011
975 INJECTION SITE ERYTHEMA 133 0.0011
976 INJECTION SITE PAIN 326 0.0011
977 DEVICE BREAKAGE 43 0.0011
978 INJECTION SITE BRUISING 80 0.0010
979 PRODUCT DOSE OMISSION 63 0.0010
980 DISEASE RECURRENCE 44 0.0009
981 ACNE 69 0.0009
982 RENAL CANCER 43 0.0009
983 MULTIPLE SCLEROSIS RELAPSE 58 0.0008
984 PRODUCT SUBSTITUTION ISSUE 48 0.0008
985 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 159 0.0008
986 INJECTION SITE HAEMORRHAGE 61 0.0008
987 THERAPY INTERRUPTED 52 0.0007
988 INJECTION SITE PRURITUS 47 0.0007
989 SKIN BURNING SENSATION 50 0.0007
990 INJECTION SITE SWELLING 52 0.0007
991 PROSTATE CANCER 51 0.0006
992 ACCIDENTAL EXPOSURE TO PRODUCT 49 0.0005
993 NO ADVERSE EVENT 78 0.0004